跳至主要内容
临床试验/NCT04285918
NCT04285918招募中不适用

Evaluation of Prevalence and Clinical Impact of Atrial Fibrillation in Elderly Patients With Cryptogenic Stroke and High-Risk Patent Foramen Ovale

Asan Medical Center1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2019年10月2日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
1
主要终点
Paroxysmal AF episodes > 30 seconds detected with intermittent recordings or ≥ 2 minutes during ICM within 6 months

研究概览

简要总结

The purpose of DEFENSE-ELDERLY is to identify the prevalence of AF and evaluate the clinical impact of AF in elderly ESUS patients and no other known sources of stroke besides a high-risk patent foramen ovale, and compare it with elderly ESUS patients without high-risk PFO (no PFO or non-high risk PFOs)

详细描述

The purpose of DEFENSE-ELDERLY is to identify the prevalence of AF and evaluate the clinical impact of AF in elderly ESUS patients and no other known sources of stroke besides a high-risk patent foramen ovale, and compare it with elderly ESUS patients without high-risk PFO (no PFO or non-high risk PFOs)

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
60 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients ≥60 y/o with ESUS and PFO that is likely to have causative role (high-risk anatomical feature) (cohort A)
  • Patients ≥60 y/o with ESUS without PFO, or with non-high risk PFO (cohort B)
  • The patient or guardian agrees to the study protocol and the schedule of clinical follow-up, and provides informed, written consent, as approved by the institutional review board
  • Patients who are scheduled to have implantable cardiac monitoring

排除标准

  • Transient ischemic attack
  • Lacunar infarction (infarction at subcortical area with a lesion diameter less than 2cm on MR)
  • Presence of complex aortic atheroma (≥4mm in plaque thickness or presence of mobile components)
  • Presence of ≥50% luminal stenosis (extra- or intracranial) in arteries supplying the ischemic area
  • Unwillingness or inability to comply with the procedures described in this protocol
  • Life expectancy < 1 years for any non-cardiac or cardiac causes

结局指标

主要结局

Paroxysmal AF episodes > 30 seconds detected with intermittent recordings or ≥ 2 minutes during ICM within 6 months

时间窗: Enrollment to 6 months

Paroxysmal AF episodes \> 30 seconds detected with intermittent recordings or ≥ 2 minutes during ICM within 6 months

次要结局

  • Paroxysmal AF episodes > 30 seconds detected with intermittent recordings or ≥ 2 minutes during ICM within 36 months(Enrollment to 36 months)
  • Paroxysmal AF episodes > 30 seconds detected with intermittent recordings or ≥ 6 minutes during ICM at 6 months and 36 months(6 months to 36 months)
  • Rates of percutaneous device closure, prescription of anticoagulants (warfarin or direct oral anticoagulants)(Enrollment to 36 months)
  • Recurrent stroke or TIA(Enrollment to 36 months)
  • All-cause death, Vascular Death(Enrollment to 36 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jae-Kwan Song

Jae-Kwan Song

Asan Medical Center

研究点 (1)

Loading locations...

相似试验